Citations (2)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giovanni Cenderello, Lucia Taramasso, Domenico Marra, Patrizia Orcamo, Ambra Pasa & Antonio Di Biagio. (2019) HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 189-193.
Read now
Read now
Articles from other publishers (1)
. (2017) DAAs are major contributor to costs of HCV in Italy. PharmacoEconomics & Outcomes News 779:1, pages 14-14.
Crossref
Crossref